Balance Sheet Shin-Etsu Chemical Co., Ltd.

Equities

4063

JP3371200001

Diversified Chemicals

Market Closed - Japan Exchange Other stock markets 12:00:00 16/03/2026 pm IST			5-day change	1st Jan Change
6,505.00 ^JPY	-0.40%		+4.13%	+33.49%

03:10pm	Shin-Etsu Chemical Co Ltd to raise PVC resin prices by 30 yen per kg from April 1	RE
12/03	Oil, Middle East Outlooks Undercut Asian Stock Markets	MT

3339007b7d2.ajy9J489LeKJqylpvqSlkHJzco9HuIRZg7gcYeWEuDA.IHWLFclnSZO96HkD0fvDxkMJQ8sk6NUMt41qM4zc51wMeukSuFRmrev0Wg

Published financial data: SHIN-ETSU CHEMICAL CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	1,49700Cr	2,07400Cr	2,80900Cr	2,41500Cr	2,56100Cr
Total Revenues	1,49700Cr	2,07400Cr	2,80900Cr	2,41500Cr	2,56100Cr
Cost of Goods Sold, Total	95TCr	1,20600Cr	1,59500Cr	1,50400Cr	1,57700Cr
Gross Profit	54TCr	87TCr	1,21400Cr	91TCr	98TCr
Selling General & Admin Expenses, Total	15TCr	19TCr	21TCr	20TCr	24TCr
Provision for Bad Debts	-51Cr	362.9Cr	-44Cr	58Cr	206.8Cr
R&D Expenses	-	-	-	-	-
Depreciation & Amortization - (IS)	266.5Cr	301.4Cr	325.2Cr	515.3Cr	487.6Cr
Other Operating Expenses, Total	15TCr	20TCr	22TCr	21TCr	24TCr
Operating Income	39TCr	67TCr	1LCr	70TCr	74TCr
Interest Expense, Total	-73Cr	-	-149Cr	-150.1Cr	-
Interest And Investment Income	1.24TCr	-	1.66TCr	6.8TCr	8.67TCr
Net Interest Expenses	1.17TCr	-	1.51TCr	6.65TCr	8.67TCr
Income (Loss) On Equity Invest.	536.4Cr	714Cr	952.2Cr	-	-
Currency Exchange Gains (Loss)	-	1.43TCr	-319.5Cr	1.36TCr	-1.07TCr
Other Non Operating Income (Expenses)	-223Cr	315.9Cr	550.6Cr	831Cr	662Cr
EBT, Excl. Unusual Items	41TCr	70TCr	1,02500Cr	79TCr	82TCr
Gain (Loss) On Sale Of Investments	-	-	-	1.92TCr	1.64TCr
Gain (Loss) On Sale Of Assets	-195.4Cr	-111.1Cr	-491Cr	-222.6Cr	-422.8Cr
Asset Writedown	-	-	-	-	-289.6Cr
Other Unusual Items	-295.5Cr	-	-	-1.07TCr	-784.2Cr
EBT, Incl. Unusual Items	40TCr	70TCr	1,02000Cr	80TCr	83TCr
Income Tax Expense	10TCr	17TCr	26TCr	23TCr	25TCr
Earnings From Continuing Operations	30TCr	53TCr	76TCr	57TCr	58TCr
Net Income to Company	30TCr	53TCr	76TCr	57TCr	58TCr
Minority Interest	-544.4Cr	-2.49TCr	-5.54TCr	-4.5TCr	-4.61TCr
Net Income - (IS)	29TCr	50TCr	71TCr	52TCr	53TCr
Net Income to Common Incl Extra Items	29TCr	50TCr	71TCr	52TCr	53TCr
Net Income to Common Excl. Extra Items	29TCr	50TCr	71TCr	52TCr	53TCr
Per Share Items
Net EPS - Basic	141.35	240.76	347.84	259.41	269.52
Basic EPS - Continuing Operations	141.35	240.76	347.84	259.41	269.52
Basic Weighted Average Shares Outstanding	207.8Cr	207.72Cr	203.61Cr	200.51Cr	198.14Cr
Net EPS - Diluted	141.25	240.55	347.61	259.13	269.27
Diluted EPS - Continuing Operations	141.25	240.55	347.61	259.13	269.27
Diluted Weighted Average Shares Outstanding	207.94Cr	207.89Cr	203.74Cr	200.7Cr	198.3Cr
Normalized Basic EPS	119.81	197.79	287.47	223.63	236.91
Normalized Diluted EPS	119.73	197.63	287.29	223.41	236.72
Dividend Per Share	50	80	100	100	106
Payout Ratio	31.12	24.09	27.58	40.61	38.34
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	54TCr	84TCr	1,21200Cr	93TCr	98TCr
EBITA	39TCr	67TCr	1LCr	70TCr	74TCr
EBIT	39TCr	67TCr	1LCr	70TCr	74TCr
Effective Tax Rate - (Ratio)	25.6	24.58	25.15	28.97	29.79
Normalized Net Income	25TCr	41TCr	59TCr	45TCr	47TCr
Non-Cash Pension Expense	-70L	-25Cr	-179.3Cr	-309.8Cr	-340.1Cr
Supplemental Operating Expense Items
Selling and Marketing Expenses	4.45TCr	6.69TCr	7.54TCr	5.78TCr	6.92TCr
Research And Development Expense From Footnotes	5.13TCr	6.25TCr	6.72TCr	6.68TCr	7.31TCr

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	87TCr	1,11300Cr	1,45000Cr	1,69900Cr	1,70800Cr
Short Term Investments	29TCr	32TCr	15TCr	2.07TCr	10TCr
Total Cash And Short Term Investments	1,15300Cr	1,43600Cr	1,60100Cr	1,72000Cr	1,81200Cr
Accounts Receivable, Total	34TCr	47TCr	47TCr	47TCr	50TCr
Total Receivables	34TCr	47TCr	47TCr	47TCr	50TCr
Inventory	37TCr	45TCr	69TCr	72TCr	77TCr
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	5.91TCr	8.05TCr	11TCr	12TCr	12TCr
Total Current Assets	1,91500Cr	2,43800Cr	2,86400Cr	3,03700Cr	3,21000Cr
Net Property Plant And Equipment	1,16500Cr	1,29000Cr	1,51800Cr	1,74700Cr	2,06600Cr
Long-term Investments	23TCr	25TCr	26TCr	28TCr	23TCr
Other Intangibles, Total	892.2Cr	1.05TCr	1.04TCr	1.02TCr	3.69TCr
Deferred Tax Assets Long-Term	5.87TCr	6.56TCr	7.5TCr	7.13TCr	9.02TCr
Other Long-Term Assets, Total	-	30L	10L	10L	10L
Total Assets	3,38100Cr	4,05300Cr	4,73000Cr	5,14800Cr	5,63700Cr
Liabilities
Accounts Payable, Total	13TCr	18TCr	19TCr	16TCr	18TCr
Accrued Expenses, Total	7.36TCr	7.39TCr	9.05TCr	9.4TCr	10TCr
Short-term Borrowings	1.18TCr	1.35TCr	1.1TCr	1.04TCr	938.9Cr
Current Income Taxes Payable	11TCr	16TCr	16TCr	19TCr	17TCr
Other Current Liabilities	4.08TCr	5.76TCr	6.37TCr	6.63TCr	6.63TCr
Total Current Liabilities	36TCr	48TCr	51TCr	52TCr	54TCr
Long-Term Debt	1.6TCr	1.69TCr	1.88TCr	1.39TCr	745.2Cr
Pension & Other Post Retirement Benefits	4.15TCr	4.15TCr	3.69TCr	3.26TCr	3.32TCr
Deferred Tax Liability Non Current	5.53TCr	6.68TCr	11TCr	13TCr	19TCr
Other Non Current Liabilities	1.8TCr	2.12TCr	2.84TCr	2.78TCr	2.95TCr
Total Liabilities	49TCr	62TCr	70TCr	72TCr	80TCr
Common Stock, Total	12TCr	12TCr	12TCr	12TCr	12TCr
Additional Paid In Capital	13TCr	13TCr	13TCr	13TCr	13TCr
Retained Earnings	2,61600Cr	2,99300Cr	3,31000Cr	3,52000Cr	3,75500Cr
Treasury Stock	-1.26TCr	-1.57TCr	-2.29TCr	-2.43TCr	-12TCr
Comprehensive Income and Other	-3.67TCr	10TCr	34TCr	52TCr	78TCr
Total Common Equity	2,81500Cr	3,32900Cr	3,87400Cr	4,26300Cr	4,66200Cr
Minority Interest	7.15TCr	9.99TCr	15TCr	16TCr	18TCr
Total Equity	2,88700Cr	3,42900Cr	4,02600Cr	4,42400Cr	4,83800Cr
Total Liabilities And Equity	3,38100Cr	4,05300Cr	4,73000Cr	5,14800Cr	5,63700Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	207.77Cr	207.72Cr	201.75Cr	199.48Cr	196.01Cr
ECS Total Common Shares Outstanding	207.77Cr	207.72Cr	201.75Cr	199.61Cr	196.01Cr
Book Value / Share	1.35T	1.6T	1.92T	2.14T	2.38T
Tangible Book Value	2,80600Cr	3,31900Cr	3,86400Cr	4,25300Cr	4,62600Cr
Tangible Book Value Per Share	1.35T	1.6T	1.92T	2.13T	2.36T
Total Debt	2.78TCr	3.04TCr	2.98TCr	2.43TCr	1.68TCr
Net Debt	-1,12500Cr	-1,40600Cr	-1,57100Cr	-1,69500Cr	-1,79500Cr
Debt Equivalent of Unfunded Proj. Benefit Obligation	3.77TCr	3.75TCr	3.3TCr	2.76TCr	2.62TCr
Minority Interest, Total (Incl. Fin. Div)	7.15TCr	9.99TCr	15TCr	16TCr	18TCr
Inventories - Raw Materials, Total	19TCr	24TCr	36TCr	40TCr	41TCr
Inventories - Work In Process, Total	1.31TCr	1.54TCr	2.14TCr	2.33TCr	2.3TCr
Inventories - Finished Goods, Total	16TCr	20TCr	31TCr	30TCr	34TCr
Full Time Employees	24.07T	24.95T	25.72T	26T	27.27T
Accumulated Allowance for Doubtful Accounts (Supple)	602.8Cr	581.8Cr	569.5Cr	704.9Cr	994.1Cr

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	40TCr	70TCr	1,02000Cr	80TCr	83TCr
Depreciation & Amortization - CF	14TCr	17TCr	21TCr	23TCr	24TCr
Depreciation & Amortization, Total	14TCr	17TCr	21TCr	23TCr	24TCr
(Gain) Loss From Sale Of Asset	94Cr	108.6Cr	151Cr	2.19TCr	352.7Cr
(Gain) Loss on Sale of Investments - (CF)	-116.7Cr	-12Cr	-5.8Cr	-1.88TCr	-1.03TCr
(Income) Loss On Equity Investments - (CF)	-536.4Cr	-714Cr	-952.2Cr	-860.7Cr	-635.1Cr
Other Operating Activities, Total	-9.87TCr	-15TCr	-26TCr	-21TCr	-18TCr
Change In Accounts Receivable	-2.2TCr	-12TCr	2.97TCr	703.9Cr	2.17TCr
Change In Inventories	-389.8Cr	-6.91TCr	-21TCr	-956Cr	-846.9Cr
Change In Accounts Payable	-958.4Cr	4.74TCr	-170.2Cr	-2.88TCr	-1.24TCr
Change in Other Net Operating Assets	-502.9Cr	-1.92TCr	858.4Cr	-1.97TCr	1.17TCr
Cash from Operations	40TCr	55TCr	79TCr	76TCr	88TCr
Capital Expenditure	-24TCr	-20TCr	-30TCr	-37TCr	-44TCr
Sale of Property, Plant, and Equipment	383.6Cr	234.5Cr	28Cr	154.5Cr	9.2Cr
Cash Acquisitions	-	-355.2Cr	-	-	-4.72TCr
Sale (Purchase) of Intangible assets	-117.7Cr	-178.1Cr	-385Cr	-306.1Cr	-336.4Cr
Investment in Marketable and Equity Securities, Total	-1.76TCr	-5.49TCr	11TCr	-72TCr	34TCr
Net (Increase) Decrease in Loans Originated / Sold - Investing	39Cr	25Cr	-15Cr	-18Cr	-20Cr
Other Investing Activities, Total	5.1Cr	-32Cr	30Cr	-174.8Cr	529.4Cr
Cash from Investing	-25TCr	-25TCr	-19TCr	-1,09900Cr	-14TCr
Short Term Debt Issued, Total	70Cr	-	-	-	284.3Cr
Long-Term Debt Issued, Total	457.8Cr	467.7Cr	500Cr	2.3Cr	122.3Cr
Total Debt Issued	527.9Cr	467.7Cr	500Cr	2.3Cr	406.6Cr
Short Term Debt Repaid, Total	-	-110Cr	-152.1Cr	-153.1Cr	-
Long-Term Debt Repaid, Total	-80Cr	-304.1Cr	-602.9Cr	-510.9Cr	-1.26TCr
Total Debt Repaid	-80Cr	-414.1Cr	-755Cr	-664Cr	-1.26TCr
Issuance of Common Stock	515Cr	263.4Cr	281.1Cr	662.1Cr	247.1Cr
Repurchase of Common Stock	-1.07TCr	-595.4Cr	-21TCr	-11TCr	-19TCr
Common Dividends Paid	-9.14TCr	-12TCr	-20TCr	-21TCr	-20TCr
Common & Preferred Stock Dividends Paid	-9.14TCr	-12TCr	-20TCr	-21TCr	-20TCr
Other Financing Activities, Total	132.1Cr	76Cr	-2.17TCr	-5.05TCr	-5.01TCr
Cash from Financing	-9.11TCr	-12TCr	-42TCr	-37TCr	-45TCr
Foreign Exchange Rate Adjustments	-286.1Cr	3TCr	6.05TCr	5.63TCr	812.5Cr
Miscellaneous Cash Flow Adjustments	-20L	6.3Cr	-10L	-	-10L
Net Change in Cash	5.65TCr	21TCr	24TCr	-66TCr	29TCr
Supplemental Items
Cash Interest Paid	57Cr	82Cr	123.4Cr	129.8Cr	115.4Cr
Cash Income Tax Paid (Refund)	10TCr	15TCr	27TCr	21TCr	19TCr
Levered Free Cash Flow	11TCr	26TCr	31TCr	25TCr	20TCr
Unlevered Free Cash Flow	11TCr	26TCr	31TCr	25TCr	20TCr
Change In Net Working Capital	4.33TCr	13TCr	23TCr	4.07TCr	6.35TCr
Net Debt Issued / Repaid	448.3Cr	54Cr	-255Cr	-661.7Cr	-857.1Cr

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	7.42	11.31	14.21	8.87	8.6
Return on Total Capital	8.66	13.19	16.6	10.3	9.97
Return On Equity %	10.67	16.63	20.48	13.38	12.53
Return on Common Equity	10.74	16.28	19.66	12.78	11.97
Margin Analysis
Gross Profit Margin %	36.32	41.84	43.22	37.73	38.42
SG&A Margin	9.98	9.1	7.59	8.47	9.18
EBITDA Margin %	35.81	40.56	43.14	38.45	38.28
EBITA Margin %	26.2	32.43	35.54	29.03	28.97
EBIT Margin %	26.2	32.43	35.54	29.03	28.97
Income From Continuing Operations Margin %	19.99	25.31	27.19	23.4	22.65
Net Income Margin %	19.62	24.11	25.21	21.54	20.85
Net Avail. For Common Margin %	19.62	24.11	25.21	21.54	20.85
Normalized Net Income Margin	16.63	19.81	20.84	18.57	18.33
Levered Free Cash Flow Margin	7.2	12.75	10.99	10.21	7.65
Unlevered Free Cash Flow Margin	7.23	12.75	11.02	10.25	7.65
Asset Turnover
Asset Turnover	0.45	0.56	0.64	0.49	0.47
Fixed Assets Turnover	1.31	1.69	2	1.48	1.34
Receivables Turnover (Average Receivables)	4.56	5.15	6.01	5.13	5.23
Inventory Turnover (Average Inventory)	2.61	2.95	2.79	2.13	2.12
Short Term Liquidity
Current Ratio	5.27	5.1	5.64	5.84	5.98
Quick Ratio	4.1	3.98	4.07	4.22	4.31
Operating Cash Flow to Current Liabilities	1.1	1.16	1.55	1.45	1.64
Days Sales Outstanding (Average Receivables)	80	70.87	60.72	71.35	69.79
Days Outstanding Inventory (Average Inventory)	139.9	123.85	130.71	171.49	172.49
Average Days Payable Outstanding	50.17	42.71	36.18	41.27	38.79
Cash Conversion Cycle (Average Days)	169.73	152	155.25	201.57	203.49
Long Term Solvency
Total Debt/Equity	0.96	0.89	0.74	0.55	0.35
Total Debt / Total Capital	0.95	0.88	0.73	0.55	0.35
LT Debt/Equity	0.55	0.49	0.47	0.31	0.15
Long-Term Debt / Total Capital	0.55	0.49	0.46	0.31	0.15
Total Liabilities / Total Assets	14.61	15.4	14.89	14.06	14.18
EBIT / Interest Expense	538.76	-	669.93	467.05	-
EBITDA / Interest Expense	736.29	-	813.31	618.69	-
(EBITDA - Capex) / Interest Expense	411.85	-	614.98	369.25	-
Total Debt / EBITDA	0.05	0.04	0.02	0.03	0.02
Net Debt / EBITDA	-2.1	-1.67	-1.3	-1.83	-1.83
Total Debt / (EBITDA - Capex)	0.09	0.05	0.03	0.04	0.03
Net Debt / (EBITDA - Capex)	-3.75	-2.18	-1.71	-3.06	-3.32
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-3.02	38.58	35.4	-14.02	6.06
Gross Profit, 1 Yr. Growth %	-2.17	59.65	39.87	-24.95	8
EBITDA, 1 Yr. Growth %	-0.22	56.98	44.01	-23.37	5.58
EBITA, 1 Yr. Growth %	-3.41	71.51	48.39	-29.77	5.86
EBIT, 1 Yr. Growth %	-3.41	71.51	48.39	-29.77	5.86
Earnings From Cont. Operations, 1 Yr. Growth %	-6.01	75.49	45.44	-25.99	2.64
Net Income, 1 Yr. Growth %	-6.46	70.26	41.61	-26.56	2.67
Normalized Net Income, 1 Yr. Growth %	-3.18	65.03	42.46	-23.39	4.69
Diluted EPS Before Extra, 1 Yr. Growth %	-6.46	70.3	44.51	-25.45	3.91
Accounts Receivable, 1 Yr. Growth %	6.15	38.43	-0.18	1.69	6.32
Inventory, 1 Yr. Growth %	-0.17	24.28	51.76	4.67	6.84
Net Property, Plant and Equip., 1 Yr. Growth %	4.04	10.73	17.67	15.04	18.29
Total Assets, 1 Yr. Growth %	4.65	19.9	16.7	8.83	9.49
Tangible Book Value, 1 Yr. Growth %	6.13	18.26	16.42	10.06	8.77
Common Equity, 1 Yr. Growth %	6.06	18.26	16.37	10.03	9.38
Cash From Operations, 1 Yr. Growth %	-2.72	37.98	42.36	-4.17	16.78
Capital Expenditures, 1 Yr. Growth %	-11.99	-17.11	50.95	26.7	17.38
Levered Free Cash Flow, 1 Yr. Growth %	51.07	145.43	16.7	-20.12	-20.58
Unlevered Free Cash Flow, 1 Yr. Growth %	50.72	144.4	17.05	-20.06	-20.89
Dividend Per Share, 1 Yr. Growth %	13.64	60	25	0	6
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-3.09	15.93	36.98	7.9	-4.51
Gross Profit, 2 Yr. CAGR %	-0.94	24.98	49.43	2.46	-9.97
EBITDA, 2 Yr. CAGR %	-0.49	25.15	50.36	5.05	-10.05
EBITA, 2 Yr. CAGR %	-1.43	28.71	59.53	2.09	-13.78
EBIT, 2 Yr. CAGR %	-1.43	28.71	59.53	2.09	-13.78
Earnings From Cont. Operations, 2 Yr. CAGR %	-2.39	28.43	59.76	3.75	-12.84
Net Income, 2 Yr. CAGR %	-2.52	26.2	55.28	1.98	-13.17
Normalized Net Income, 2 Yr. CAGR %	-1.64	26.41	53.33	4.47	-10.45
Diluted EPS Before Extra, 2 Yr. CAGR %	-1.36	26.21	56.87	3.79	-11.99
Accounts Receivable, 2 Yr. CAGR %	0.98	21.22	17.55	0.75	3.98
Inventory, 2 Yr. CAGR %	5.25	11.38	37.33	26.04	5.75
Net Property, Plant and Equip., 2 Yr. CAGR %	8.6	7.33	14.15	16.35	16.65
Total Assets, 2 Yr. CAGR %	5.48	12.02	18.29	12.7	9.16
Tangible Book Value, 2 Yr. CAGR %	6.85	12.03	17.34	13.2	9.41
Common Equity, 2 Yr. CAGR %	6.83	12	17.31	13.15	9.7
Cash From Operations, 2 Yr. CAGR %	0.06	15.86	40.15	16.8	5.79
Capital Expenditures, 2 Yr. CAGR %	2.06	-14.59	11.86	38.29	21.95
Levered Free Cash Flow, 2 Yr. CAGR %	-15.14	92.56	69.24	-3.45	-20.35
Unlevered Free Cash Flow, 2 Yr. CAGR %	-15.1	91.93	69.13	-3.27	-20.47
Dividend Per Share, 2 Yr. CAGR %	11.8	34.84	41.42	11.8	2.96
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	1.27	9.18	22.09	17.28	7.28
Gross Profit, 3 Yr. CAGR %	4.36	16.14	29.76	18.78	4.27
EBITDA, 3 Yr. CAGR %	6.1	15.84	31.15	20.1	5.23
EBITA, 3 Yr. CAGR %	5.21	18.55	34.96	21.36	3.33
EBIT, 3 Yr. CAGR %	5.21	18.55	34.96	21.36	3.33
Earnings From Cont. Operations, 3 Yr. CAGR %	3.47	18.69	33.87	23.62	3.38
Net Income, 3 Yr. CAGR %	3.33	17.39	31.14	20.98	2.21
Normalized Net Income, 3 Yr. CAGR %	5.69	16.88	31.55	21.67	4.54
Diluted EPS Before Extra, 3 Yr. CAGR %	4.21	18.33	32.04	22.42	3.83
Accounts Receivable, 3 Yr. CAGR %	1.76	12.18	13.62	12.01	2.57
Inventory, 3 Yr. CAGR %	8.97	11.25	23.48	25.45	19.28
Net Property, Plant and Equip., 3 Yr. CAGR %	9	9.3	10.67	14.45	16.99
Total Assets, 3 Yr. CAGR %	5.14	10.08	13.56	15.05	11.62
Tangible Book Value, 3 Yr. CAGR %	6.21	10.53	13.48	14.86	11.7
Common Equity, 3 Yr. CAGR %	6.18	10.51	13.44	14.83	11.88
Cash From Operations, 3 Yr. CAGR %	6.43	11.37	24.09	23.47	16.8
Capital Expenditures, 3 Yr. CAGR %	13.32	-4.78	3.26	16.6	30.94
Levered Free Cash Flow, 3 Yr. CAGR %	-10.95	20.9	62.95	31.77	-9.54
Unlevered Free Cash Flow, 3 Yr. CAGR %	-10.9	20.78	62.76	31.75	-9.54
Dividend Per Share, 3 Yr. CAGR %	21.32	25.99	31.48	25.99	9.83
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	3.18	10.89	14.27	8.66	10.66
Gross Profit, 5 Yr. CAGR %	9.22	18.66	20.47	10.46	12.11
EBITDA, 5 Yr. CAGR %	11.65	20.46	21.97	11.4	12.79
EBITA, 5 Yr. CAGR %	13.47	23.03	24.27	11.67	12.82
EBIT, 5 Yr. CAGR %	13.47	23.03	24.27	11.67	12.82
Earnings From Cont. Operations, 5 Yr. CAGR %	14.75	24.11	23.11	12.47	12.76
Net Income, 5 Yr. CAGR %	14.56	23.24	21.61	10.97	11.2
Normalized Net Income, 5 Yr. CAGR %	12.72	22.4	22.65	11.75	12.79
Diluted EPS Before Extra, 5 Yr. CAGR %	15.11	23.85	22.73	12.28	12.26
Accounts Receivable, 5 Yr. CAGR %	5.87	11.34	7.8	7.46	9.66
Inventory, 5 Yr. CAGR %	5.37	11.17	19.54	16.94	16.06
Net Property, Plant and Equip., 5 Yr. CAGR %	7.68	8.79	11.03	12.07	13.03
Total Assets, 5 Yr. CAGR %	6.14	8.83	10.22	11.12	11.78
Tangible Book Value, 5 Yr. CAGR %	6.84	9.35	10.53	11.59	11.83
Common Equity, 5 Yr. CAGR %	6.77	9.31	10.5	11.56	11.93
Cash From Operations, 5 Yr. CAGR %	7.33	13.73	18.82	13.51	16.42
Capital Expenditures, 5 Yr. CAGR %	9.91	7.73	12.73	10.55	10.37
Levered Free Cash Flow, 5 Yr. CAGR %	6.25	12.86	15.13	10.5	22.38
Unlevered Free Cash Flow, 5 Yr. CAGR %	6.27	12.81	15.14	10.51	22.22
Dividend Per Share, 5 Yr. CAGR %	17.84	27.23	28.99	20.11	19.23